{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:09:33Z","timestamp":1789877373198,"version":"4.0.1"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T00:00:00Z","timestamp":1389139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0083113","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T16:34:29Z","timestamp":1389198869000},"page":"e83113","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":85,"title":["High Serum miR-19a Levels Are Associated with Inflammatory Breast Cancer and Are Predictive of Favorable Clinical Outcome in Patients with Metastatic HER2+ Inflammatory Breast Cancer"],"prefix":"10.1371","volume":"9","author":[{"given":"Simone","family":"Anfossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan N.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanda","family":"Tin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul J.","family":"Garza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bisrat G.","family":"Debeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo H.","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Valero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel N.","family":"Hortobagyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Calin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto T.","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy A.","family":"Woodward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Reuben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,1,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"A Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3233\/BD-2006-22103","article-title":"Epidemiology of inflammatory breast cancer (IBC)","volume":"22","author":"WF Anderson","year":"2005","journal-title":"Breast Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1186\/bcr89","article-title":"Molecular biology of breast cancer metastasis. Inflammatory breast cancer: clinical syndrome and molecular determinants","volume":"2","author":"CG Kleer","year":"2000","journal-title":"Breast Cancer Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/cncr.22927","article-title":"Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique disease","volume":"110","author":"M Cristofanilli","year":"2007","journal-title":"Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ncponc1298","article-title":"Trastuzumab as adjuvant systemic therapy for HER2-positive breast cancer","volume":"6","author":"G Mariani","year":"2009","journal-title":"Nat Clin Pract Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ncponc0509","article-title":"Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer","volume":"3","author":"R Nahta","year":"2006","journal-title":"Nat Clin Pract Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.0307323101","article-title":"Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers","volume":"101","author":"GA Calin","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1158\/0008-5472.CAN-05-1783","article-title":"MicroRNA gene expression deregulation in human breast cancer","volume":"65","author":"MV Iorio","year":"2005","journal-title":"Cancer Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2141.2008.07077.x","article-title":"Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma","volume":"141","author":"CH Lawrie","year":"2008","journal-title":"Br J Haematol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"PS Mitchell","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/gut.2008.167817","article-title":"Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening","volume":"58","author":"EK Ng","year":"2009","journal-title":"Gut"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1200\/JCO.2009.24.9342","article-title":"Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer","volume":"28","author":"Z Hu","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ygyno.2008.04.033","article-title":"MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer","volume":"110","author":"DD Taylor","year":"2008","journal-title":"Gynecol Oncol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"R34","DOI":"10.1186\/bcr3127","article-title":"Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers","volume":"14","author":"E van Schooneveld","year":"2012","journal-title":"Breast Cancer Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/1476-4598-9-306","article-title":"Serum microRNAs as non-invasive biomarkers for cancer","volume":"9","author":"JC Brase","year":"2010","journal-title":"Mol Cancer"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"H Valadi","year":"2007","journal-title":"Nat Cell Biol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"ra81","DOI":"10.1126\/scisignal.2000610","article-title":"Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection","volume":"2","author":"A Zernecke","year":"2009","journal-title":"Sci Signal"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1517\/14712590902932889","article-title":"MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases","volume":"9","author":"MA Cortez","year":"2009","journal-title":"Expert Opin Biol Ther"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e3694","DOI":"10.1371\/journal.pone.0003694","article-title":"Detection of microRNA expression in human peripheral blood microvesicles","volume":"3","author":"MP Hunter","year":"2008","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1073\/pnas.1019055108","article-title":"Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma","volume":"108","author":"JD Arroyo","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/cr.2008.282","article-title":"Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases","volume":"18","author":"X Chen","year":"2008","journal-title":"Cell Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1038\/sj.onc.1210083","article-title":"miR-21-mediated tumor growth","volume":"26","author":"ML Si","year":"2007","journal-title":"Oncogene"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"R2","DOI":"10.1186\/bcr2803","article-title":"Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth","volume":"13","author":"LX Yan","year":"2011","journal-title":"Breast Cancer Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e19139","DOI":"10.1371\/journal.pone.0019139","article-title":"MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1alpha expression","volume":"6","author":"LZ Liu","year":"2011","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1261\/rna.1034808","article-title":"MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis","volume":"14","author":"LX Yan","year":"2008","journal-title":"RNA"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"19127","DOI":"10.1074\/jbc.M110.216887","article-title":"Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer","volume":"286","author":"C Gong","year":"2011","journal-title":"J Biol Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature06174","article-title":"Tumour invasion and metastasis initiated by microRNA-10b in breast cancer","volume":"449","author":"L Ma","year":"2007","journal-title":"Nature"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1101\/gad.1861409","article-title":"miR-19 is a key oncogenic component of mir-17\u201392","volume":"23","author":"V Olive","year":"2009","journal-title":"Genes Dev"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1101\/gad.1872909","article-title":"Genetic dissection of the miR-17\u223c92 cluster of microRNAs in Myc-induced B-cell lymphomas","volume":"23","author":"P Mu","year":"2009","journal-title":"Genes Dev"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"8742","DOI":"10.1158\/0008-5472.CAN-09-1541","article-title":"Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone","volume":"69","author":"S Liu","year":"2009","journal-title":"Cancer Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/ng1855","article-title":"Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster","volume":"38","author":"M Dews","year":"2006","journal-title":"Nat Genet"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1158\/1535-7163.MCT-12-0460","article-title":"Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer","volume":"11","author":"A Giordano","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1158\/1940-6207.CAPR-11-0370","article-title":"Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies","volume":"5","author":"CC Pritchard","year":"2012","journal-title":"Cancer Prev Res (Phila)"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e7405","DOI":"10.1371\/journal.pone.0007405","article-title":"MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis","volume":"4","author":"C Vasilescu","year":"2009","journal-title":"PLoS One"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e13735","DOI":"10.1371\/journal.pone.0013735","article-title":"A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer","volume":"5","author":"H Zhao","year":"2010","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/SLA.0b013e3181cc939f","article-title":"Circulating microRNAs as novel minimally invasive biomarkers for breast cancer","volume":"251","author":"HM Heneghan","year":"2010","journal-title":"Ann Surg"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"R90","DOI":"10.1186\/bcr2766","article-title":"Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer","volume":"12","author":"C Roth","year":"2010","journal-title":"Breast Cancer Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1373\/clinchem.2010.151845","article-title":"Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer","volume":"57","author":"S Asaga","year":"2011","journal-title":"Clin Chem"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"18515","DOI":"10.1074\/jbc.M109.006676","article-title":"Up-regulation of miR-21 by HER2\/neu signaling promotes cell invasion","volume":"284","author":"TH Huang","year":"2009","journal-title":"J Biol Chem"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"9965","DOI":"10.1073\/pnas.1207327109","article-title":"Temporal expression of microRNA cluster miR-17-92 regulates effector and memory CD8+ T-cell differentiation","volume":"109","author":"T Wu","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1479-5876-8-17","article-title":"miR-17-92 expression in differentiated T cells \u2013 implications for cancer immunotherapy","volume":"8","author":"K Sasaki","year":"2010","journal-title":"J Transl Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1101\/gad.1789609","article-title":"Cell contact-dependent acquisition of cellular and viral nonautonomously encoded small RNAs","volume":"23","author":"O Rechavi","year":"2009","journal-title":"Genes Dev"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.canlet.2005.01.041","article-title":"Herceptin: mechanisms of action and resistance","volume":"232","author":"R Nahta","year":"2006","journal-title":"Cancer Lett"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/jso.23312","article-title":"Serum miR-19a expression correlates with worse prognosis of patients with non-small cell lung cancer","volume":"107","author":"Q Lin","year":"2013","journal-title":"J Surg Oncol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0083113","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T13:04:35Z","timestamp":1540213475000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0083113"}},"subtitle":[],"editor":[{"given":"Gerolama","family":"Condorelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,1,8]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0083113","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,8]]}}}